TSHZ3 and cancer: The analysis revealed that TSHZ3 transcriptional levels were lower in nine cancer types, including LUAD, but higher in cholangiocarcinoma (CHOL) and head and neck squamous cell carcinoma (HNSC) compared with the normal tissues (Figure 1A).